Teva and Alvotech Boost Biosimilars Deal

Teva Expands Alvotech Collaboration with 2 New Biosimilar, $40M Investment & Enhanced Oversight

Source – Teva Pharmaceuticals Following the second FDA rejection of Teva’s Alvotech-partnered biosimilar for Humira, the two companies are expanding ...